Horizon Therapeutics Publ... (HZNP)
NASDAQ: HZNP
· Real-Time Price · USD
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Horizon Therapeutics Public Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 944.96M | 832.06M | 942.03M | 925.36M | 876.41M | 885.25M | 1.01B | 1.04B | 832.55M | 342.41M |
Cost of Revenue | 219.96M | 208.56M | 240.79M | 234.13M | 230.22M | 215.06M | 241.51M | 251.64M | 201M | 100.37M |
Gross Profit | 725M | 623.5M | 701.24M | 691.23M | 646.2M | 670.18M | 772.96M | 785.35M | 631.55M | 242.04M |
Operating Income | 142.84M | 35.99M | 173.93M | 160.61M | 142.34M | 194.32M | 233.09M | 331.54M | 138.51M | -160.02M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 135.25M | 19.2M | 154.33M | 135.08M | 64.79M | 172.74M | 211.06M | 307.24M | 115.63M | -171.1M |
Net Income | 127.07M | 54.68M | 120.41M | 135.84M | 60.97M | 204.26M | 173.18M | 326.54M | 158.12M | -123.35M |
Selling & General & Admin | 434.13M | 453.35M | 372.53M | 397.56M | 398.22M | 372.73M | 398.95M | 360.26M | 355.2M | 331.99M |
Research & Development | 150.03M | 134.15M | 117.53M | 114.06M | 103.25M | 103.13M | 140.91M | 93.55M | 139.83M | 57.69M |
Other Expenses | 4.18M | -1.34M | -159K | -2.28M | -2.39M | -742K | -322K | -849K | -262K | 3.22M |
Operating Expenses | 584.16M | 587.5M | 490.06M | 511.62M | 501.47M | 475.87M | 539.87M | 453.81M | 495.04M | 389.69M |
Interest Expense | 12.1M | 15.54M | 18.56M | 22.48M | 21.41M | 21.26M | 22.05M | 22.98M | 22.58M | 13.46M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 804.12M | 796.07M | 730.85M | 745.75M | 731.68M | 690.93M | 781.38M | 705.45M | 696.03M | 490.05M |
Income Tax Expense | 8.18M | -35.48M | 33.92M | -758K | 3.81M | -31.52M | 37.87M | -19.3M | -42.48M | -47.75M |
Shares Outstanding (Basic) | 228.74M | 228.4M | 226.97M | 230.33M | 230.02M | 229.09M | 227.04M | 226.1M | 225.12M | 223.92M |
Shares Outstanding (Diluted) | 233.94M | 233.79M | 233.01M | 235.39M | 236.17M | 235.95M | 236.95M | 236.2M | 235.19M | 223.92M |
EPS (Basic) | 0.56 | 0.24 | 0.53 | 0.59 | 0.26 | 0.87 | 0.76 | 1.44 | 0.70 | -0.55 |
EPS (Diluted) | 0.54 | 0.23 | 0.52 | 0.58 | 0.26 | 0.87 | 0.73 | 1.38 | 0.67 | -0.55 |
EBITDA | 241.31M | 129.51M | 309.8M | 276.41M | 239.76M | 288.69M | 329.3M | 425.17M | 228.17M | -73.6M |
EBIT | 147.35M | 34.74M | 172.89M | 157.56M | 139.98M | 194M | 233.1M | 330.22M | 138.21M | -144.18M |
Depreciation & Amortization | 96.28M | 93.52M | 135.87M | 115.8M | 97.43M | 95.11M | 96.53M | 94.48M | 91.92M | 70.82M |